ELIZABETH NAMAN: Open Payments
NPI 1912655887 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 32 payments from 11 companies in 2025. Trend: 2023 $607 · 2024 $1,309 · 2025 $1,033
Food & beverage: $1,028Travel & lodging: $5
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $354 |
| COLOPLAST CORP | 4 | $236 |
| Procept Biorobotics Corporation | 1 | $75 |
| Medtronic, Inc. | 3 | $65 |
| ABBVIE INC. | 4 | $63 |
| UROGEN PHARMA, INC. | 3 | $60 |
| Janssen Biotech, Inc. | 3 | $52 |
| IMMUNITYBIO, INC. | 2 | $45 |
| Myriad Genetic Laboratories, Inc. | 2 | $41 |
| Baxter Healthcare | 1 | $22 |
Products named: GEMTESA, SpeediCath, Luja Coude, AQUABEAM ROBOTIC SYSTEM, INTERSTIM, BOTOX, ERLEADA, ANKTIVA.
Industry payments across AL — which companies pay providers there.
